重组人PAI1 + PLAU蛋白(ab92553)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: SDS-PAGE
描述
-
产品名称
重组人PAI1 + PLAU蛋白 -
纯度
> 95 % SDS-PAGE.
Human PAI1 stable mutant is reacted with an excess of Human PLAU at physiological pH. Excess PLAU is removed from the resulting 1:1 molar complex by immobilized benzamidine resin. -
表达系统
Escherichia coli -
蛋白长度
Full length protein -
无动物成分
No -
性质
Recombinant -
-
种属
Human
-
相关产品
-
Related Products
技术指标
Our Abpromise guarantee covers the use of ab92553 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
应用
SDS-PAGE
-
形式
Liquid -
Concentration information loading...
制备和贮存
-
稳定性和存储
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
pH: 5
Constituents: 2.38% HEPES, 0.58% Sodium chloride
常规信息
-
别名
- ATF
- Endothelial plasminogen activator inhibitor
- PAI
see all -
相关性
PAI1 acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis. PLAU specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. -
细胞定位
Secreted
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
Datasheet download
文献 (1)
ab92553 被引用在 1 文献中.
- Gao LM et al. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter. J Cell Mol Med 23:6411-6428 (2019). PubMed: 31317666